The best indicator for Viatris (VTRS)
We backtested 20 indicators across daily, weekly and hourly charts on real Viatris (VTRS) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Holy Grail Confluence
On the weekly chart, this is the strongest risk-adjusted edge we found for Viatris (VTRS) over ~46.4 years — beating buy-and-hold by 2.8% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Holy Grail Confluence ✓ | Weekly | 9.1% | 0.49 | -62.0% | 88.9% | 18 | 2.8% |
| 2 | Bollinger Mean-Reversion ✓ | Weekly | 8.3% | 0.47 | -54.8% | 78.6% | 42 | 2.0% |
| 3 | CCI ✓ | Weekly | 7.4% | 0.41 | -59.4% | 77.6% | 49 | 1.1% |
| 4 | RSI Mean-Reversion ✓ | Weekly | 4.3% | 0.33 | -35.7% | 86.7% | 15 | -2.0% |
| 5 | WaveTrend (8/6/4) ✓ | Weekly | 5.6% | 0.33 | -65.2% | 69.4% | 36 | -0.8% |
| 6 | Holy Grail Confluence ✓ | Daily | 4.6% | 0.3 | -54.1% | 64.6% | 79 | -1.6% |
| 7 | Stochastic ✓ | Weekly | 4.0% | 0.28 | -67.6% | 62.5% | 48 | -2.3% |
| 8 | Williams %R ✓ | Daily | 3.5% | 0.26 | -80.6% | 67.3% | 278 | -2.7% |
| 9 | WaveTrend (8/6/4) | Daily | 2.6% | 0.25 | -79.3% | 64.6% | 164 | -3.5% |
| 10 | Williams %R ✓ | Weekly | 3.3% | 0.25 | -70.8% | 65.5% | 55 | -3.1% |
| 11 | Rate of Change ✓ | Weekly | 2.3% | 0.24 | -84.0% | 45.8% | 153 | -4.0% |
| 12 | Money Flow Index ✓ | Weekly | 4.8% | 0.32 | -62.8% | 81.8% | 11 | -1.5% |
| 13 | MACD ✓ | Daily | 2.0% | 0.23 | -77.6% | 39.9% | 456 | -4.2% |
| 14 | EMA 20/50 Cross ✓ | Weekly | 1.8% | 0.23 | -87.1% | 44.0% | 25 | -4.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Viatris (VTRS), Holy Grail Confluence on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.